KAT Attica General Hospital also known as KAT Hospital, is a tertiary-level hospital in the Attica region of Greece. It is located in Kifisia, a northern suburban of Athens. It was formerly known as the "Apostolos Pavlos" Accident Hospital.

There are 650 beds in KAT General Hospital of Athens.

During the past decade, KAT General Hospital of Athens conducted 12 clinical trials. In the 10-year time frame, 12 clinical trials started and 4 clinical trials were completed, i.e. on average, 33.3% percent of trials that started reached the finish line to date. In the past 5 years, 6 clinical trials started and 4 clinical trials were completed. i.e. 66.7% of trials that started reached the finish line.

Out of the total clinical trials conducted in "KAT General Hospital of Athens" #1 sponsor was "Bayer" with 7 trials, followed by "Eli Lilly and Company" with 2 trials sponsored, "Aretaieion University Hospital" with 1 trials sponsored, "Elpen Pharmaceutical Co. Inc." with 1 trials sponsored and "Evangelismos Hospital" with 1 trials sponsored. Other sponsors include -3 different institutions and companies that sponsored additional 7 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "KAT General Hospital of Athens" #1 collaborator was "KAT General Hospital" with 2 trials as a collaborator, "Bayer" with 1 trials as a collaborator, "Canadian VIGOUR Centre" with 1 trials as a collaborator, "Duke Clinical Research Institute" with 1 trials as a collaborator and "Incyte Corporation" with 1 trials as a collaborator. Other collaborators include -3 different institutions and companies that were collaborators in the rest 7 trials.

According to Clinical.Site data, the most researched conditions in "KAT General Hospital of Athens" are "Heart Failure" (3 trials), "Atrial Fibrillation" (2 trials), "Rheumatoid Arthritis" (2 trials), "Acute Brain Injury" (1 trials) and "Acute Myocardial Infarction" (1 trials). Many other conditions were trialed in "KAT General Hospital of Athens" in a lesser frequency.

Most popular intervention types in "KAT General Hospital of Athens" are "Drug" (9 trials) and "Other" (4 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (5 trials), "Apixaban" (2 trials), "Baricitinib" (2 trials), "Neladenoson bialanate (BAY1067197)" (2 trials) and "Apixaban matching placebo" (1 trials). Other intervention names were less common.

The vast majority of trials in "KAT General Hospital of Athens" are 14 trials for "All" genders.

Currently, there are NaN active trials in "KAT General Hospital of Athens". 1 are not yet recruiting, 2 are recruiting, 2 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 9 completed trials in KAT General Hospital of Athens, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in KAT General Hospital of Athens, 0 "Phase 1" clinical trials were conducted, 5 "Phase 2" clinical trials and 3 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 2 trials that are defined as “Not Applicable".